StoneX Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.2M | Sell |
42,922
-15,381
| -26% | -$1.78M | 0.28% | 64 |
|
|
2025
Q4 | $6.19M | Buy |
58,303
+74
| +0.1% | +$6.95K | 0.27% | 71 |
|
|
2025
Q3 | $4.93M | Sell |
58,229
-2,299
| -4% | -$189K | 0.22% | 94 |
|
|
2025
Q2 | $4.84M | Sell |
60,528
-2,444
| -4% | -$194K | 0.24% | 83 |
|
|
2025
Q1 | $5.69M | Buy |
62,972
+3,388
| +6% | +$316K | 0.31% | 69 |
|
|
2024
Q4 | $5.96M | Buy |
+59,584
| New | +$6.14M | 0.33% | 65 |
|
|
2022
Q2 | – | Sell |
-21,823
| Closed | -$1.81M | – | 657 |
|
|
2022
Q1 | $1.81M | Buy |
21,823
+3,652
| +20% | +$288K | 0.17% | 115 |
|
|
2021
Q4 | $1.41M | Buy |
18,171
+6,588
| +57% | +$525K | 0.16% | 130 |
|
|
2021
Q3 | $878K | Sell |
11,583
-327
| -3% | -$24.9K | 0.13% | 175 |
|
|
2021
Q2 | $934K | Buy |
11,910
+339
| +3% | +$25.2K | 0.14% | 162 |
|
|
2021
Q1 | $858K | Buy |
11,571
+473
| +4% | +$34.9K | 0.15% | 140 |
|
|
2020
Q4 | $873K | Buy |
11,098
+1,399
| +14% | +$107K | 0.19% | 110 |
|
|
2020
Q3 | $773K | Buy |
9,699
+1,150
| +13% | +$90.1K | 0.25% | 101 |
|
|
2020
Q2 | $636K | Sell |
8,549
-228
| -3% | -$17.2K | 0.24% | 108 |
|
|
2020
Q1 | $649K | Sell |
8,777
-390
| -4% | -$30.7K | 0.34% | 85 |
|
|
2019
Q4 | $801K | Buy |
9,167
+884
| +11% | +$72.6K | 0.33% | 93 |
|
|
2019
Q3 | $669K | Buy |
8,283
+1,262
| +18% | +$101K | 0.42% | 76 |
|
|
2019
Q2 | $565K | Buy |
7,021
+144
| +2% | +$11K | 0.36% | 89 |
|
|
2019
Q1 | $549K | Buy |
6,877
+732
| +12% | +$54.7K | 0.42% | 83 |
|
|
2018
Q4 | $451K | Buy |
6,145
+213
| +4% | +$15K | 0.44% | 82 |
|
|
2018
Q3 | $402K | Buy |
5,932
+295
| +5% | +$18.8K | 0.3% | 119 |
|
|
2018
Q2 | $327K | Sell |
5,637
-58
| -1% | -$3.27K | 0.28% | 125 |
|
|
2018
Q1 | $296K | Buy |
5,695
+91
| +2% | +$4.92K | 0.28% | 142 |
|
|
2017
Q4 | $301K | Sell |
5,604
-165
| -3% | -$9.15K | 0.31% | 129 |
|
|
2017
Q3 | $352K | Sell |
5,769
-41,871
| -88% | -$2.54M | 0.44% | 92 |
|
|
2017
Q2 | $2.91M | Buy |
47,640
+27,115
| +132% | +$1.65M | 0.91% | 10 |
|
|
2017
Q1 | $1.15M | Sell |
20,525
-279
| -1% | -$16.9K | 2.58% | 10 |
|
|
2016
Q4 | $1.17M | Sell |
20,804
-2,391
| -10% | -$140K | 2.04% | 11 |
|
|
2016
Q3 | $1.38M | Buy |
+23,195
| New | +$1.36M | 3.09% | 7 |
|
Other funds holding MRK
VCM
VPM
StoneX Group's MRK Position: Q1 2026 in Review
StoneX Group reduced its Merck (MRK) stake by 26% in Q1 2026, selling an estimated $1.78M and leaving 42,922 shares worth $5.2M. The position accounts for 0.28% of the portfolio, ranked #64.
StoneX Group first reported a position in MRK in Q3 2016 and has held it in 29 quarters since. The position peaked at $6.19M in Q4 2025. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- StoneX Group held 42,922 shares of Merck worth $5.2M as of Q1 2026.
- StoneX Group sold 15,381 Merck shares in Q1 2026, an estimated $1.78M.
- Merck made up 0.28% of StoneX Group's portfolio in Q1 2026, its #64 holding.
- StoneX Group first reported a position in Merck in Q3 2016 and has held it in 29 quarters since.
- StoneX Group's Merck position peaked at $6.19M in Q4 2025.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.